Wanze shares: Revenue in 2025 was 1.291 billion yuan, a year-on-year increase of 19.62%

Wanzex announced that its revenue in 2025 was 1.291 billion yuan, a year-on-year increase of 19.62%; net profit was 197 million yuan, a year-on-year increase of 2.22%. The company's main business is the research, development, production, and sales of micro-ecological live bacteria products, high-temperature alloys, and their products. In January 2025, the company canceled 8.1 million shares for repurchase. It also invested 1 billion yuan to establish an industrial mergers and acquisitions fund, with the company contributing 500 million yuan. In addition, the company implemented a stock incentive plan for 2020-2025, involving multiple batches of restricted stocks unlocking, exercising, and repurchasing and canceling.